Clinical Trials Browser

Phase 4 × exemestane × Clear all

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT03355157 2024-10-01

PADMA

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

NCT03948568 2022-09-30

REaCT-RETT

Phase 4 Completed

Breast Neoplasms

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT01176916 2021-10-27

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Phase 4 Completed

564 enrolled 13 charts

Breast Neoplasms

NCT01743560 2019-07-18

4EVERUK

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT02248571 2017-11-13

IMPROVE

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT02467686 2017-03-20

Cimicifuga

Phase 4 Unknown

Sexuality

NCT00649090 2008-09-29

A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Phase 4 Completed

Breast Neoplasms